Advertisement

Topics

LabCorp is Scheduled to Present at the 38th Annual Raymond James Institutional Investors Conference

16:45 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the 38th Annual Raymond James Institutional Investors Conference. LabCorp’s presentation is scheduled for Tuesday, Marc...

Other Sources for this Article

Laboratory Corporation of America® Holdings
Investors:
Scott Frommer, 336-436-5076
Investor@labcorp.com
or
Media:
Pattie Kushner, 336-436-8263
Media@labcorp.com
www.labcorp.com

NEXT ARTICLE

More From BioPortfolio on "LabCorp is Scheduled to Present at the 38th Annual Raymond James Institutional Investors Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...